Skip to main content

Table 4 Blood markers obtained before and after supplementation with AHE or placeboa

From: A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes

  Test group (n = 22) Placebo group (n = 22) P-valueb
Week 0 Week 8 Change value Week 0 Week 8 Change value
Insulin (μU/mL) 8.52 ± 4.38 10.41 ± 5.00 1.89 ± 3.53 9.32 ± 4.42 9.26 ± 5.19 −0.06 ± 3.08 0.094
C-peptide (ng/mL) 2.00 ± 0.77 2.23 ± 0.69 0.23 ± 0.50 2.07 ± 0.77 2.18 ± 0.90 0.11 ± 0.38 0.448
HbA1c (%) 6.24 ± 0.38 6.20 ± 0.37 −0.04 ± 0.12 6.19 ± 0.37 6.26 ± 0.39 0.07 ± 0.15 0.012
Total cholesterol (mg/dL) 213.86 ± 27.18 212.68 ± 24.87 −1.18 ± 28.03 219.27 ± 21.88 217.68 ± 25.36 −1.59 ± 18.98 0.963
Triglycerides (mg/dL) 180.77 ± 117.66 170.09 ± 109.94 −10.68 ± 34.42 160.86 ± 75.71 157.32 ± 74.26 −3.55 ± 84.89 0.730
HDL-cholesterol (mg/dL) 49.27 ± 9.52 49.68 ± 8.25 0.41 ± 5.43 50.64 ± 9.42 48.45 ± 8.32 −2.18 ± 6.18 0.201
LDL-cholesterol (mg/dL) 133.86 ± 19.11 135.23 ± 19.86 1.36 ± 25.42 145.00 ± 18.97 143.82 ± 24.50 −1.18 ± 17.76 0.759
  1. AHE Allium hookeri extract; HbA1c hemoglobin A1c
  2. aValues are presented as mean ± standard deviation
  3. bAnalyzed using t-test (difference between two groups in change from baseline)